Access to Myriad Genetics’ GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial July 12, 2022 Study showed PGx testing helps clinicians prescribe fewer medications with gene-drug interactions Major Depressive Disorder (MDD) remission rates were signif... Continue Reading